M
Muthana Al Abo
Researcher at Kyoto University
Publications - 11
Citations - 245
Muthana Al Abo is an academic researcher from Kyoto University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 4, co-authored 4 publications receiving 186 citations.
Papers
More filters
Journal ArticleDOI
SLFN11 Blocks Stressed Replication Forks Independently of ATR
Junko Murai,Sai-Wen Tang,Elisabetta Leo,Simone A Baechler,Christophe E. Redon,Hongliang Zhang,Muthana Al Abo,Vinodh N. Rajapakse,Eijiro Nakamura,Lisa M. Miller Jenkins,Mirit I. Aladjem,Yves Pommier +11 more
TL;DR: It is concluded that SLFN11 is recruited to stressed replication forks carrying extended RPA filaments where it blocks replication by changing chromatin structure across replication sites.
Journal ArticleDOI
RNF4-mediated polyubiquitination regulates the Fanconi anemia/BRCA pathway
Jenny Xie,Hyungjin Kim,Hyungjin Kim,Lisa A. Moreau,Shannon Puhalla,Judy Garber,Muthana Al Abo,Shunichi Takeda,Alan D. D'Andrea +8 more
TL;DR: Wild-type FANCA was also subject to SUMOylation, RNF4-mediated polyubiquitination, and degradation, suggesting that regulated release of FAAP20 from FAN CA is a critical step in the normal FA pathway.
Journal ArticleDOI
Compensatory functions and interdependency of the DNA-binding domain of BRCA2 with the BRCA1-PALB2-BRCA2 complex.
Muthana Al Abo,Donniphat Dejsuphong,Donniphat Dejsuphong,Kouji Hirota,Yasukazu Yonetani,Mitsuyoshi Yamazoe,Hitoshi Kurumizaka,Shunichi Takeda +7 more
TL;DR: The essential role played by both the BRCA1-PALB2-BRCA2 complex and the DBD in the functionality of BRC a2 is revealed, as each can compensate for the other in the recruitment of B RCA2 to DNA-damage sites.
Journal ArticleDOI
TDP1 is Critical for the Repair of DNA Breaks Induced by Sapacitabine, a Nucleoside also Targeting ATM- and BRCA-Deficient Tumors.
Muthana Al Abo,Hiroyuki Sasanuma,Xiaojun Liu,Vinodh N. Rajapakse,Shar yin Huang,Evgeny Kiselev,Shunichi Takeda,William Plunkett,Yves Pommier +8 more
TL;DR: The importance of TDP1 is identified as a novel determinant of response to CNDAC across various cancer types (especially non–small cell lung cancers), and the differential involvement of BRCA2, PARP1, and T DP1 in the cellular responses to C NDAC, AraC, and CPT is demonstrated.
Journal ArticleDOI
A widespread length-dependent splicing dysregulation in cancer
Sirui Zhang,Miaowei Mao,Yuesheng Lv,Yingqun Yang,Weijing He,Yongmei Song,Yong Wang,Yun-Seok Yang,Muthana Al Abo,Jennifer A. Freedman,Steven R. Patierno,Yang Wang,Zefeng Wang +12 more
TL;DR: It is found that short exons are more likely to be mis-spliced and preferentially excluded in cancers, and a CASE-based panel is developed as reliable cancer stratification markers and strong predictors for survival, clinically useful because the detection of short exon splicing is practical.